[Clinical trial of Clonazepam (Ro 5-4023 Roche) in the pediatric age].
D000927:Anticonvulsants / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003975:Diazepam / Q000627:therapeutic use; D004569:Electroencephalography; D004832:Epilepsy, Absence / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D006801:Humans; D007223:Infant; D007659:Ketones / Q000627:therapeutic use; D009574:Nitro Compounds / Q000627:therapeutic use; D011596:Psychomotor Disorders / Q000188:drug therapy; D012021:Reflex, Abnormal; D012640:Seizures / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000927:Anticonvulsants; D001552:Benzazepines; D007659:Ketones; D009574:Nitro Compounds; D014149:Tranquilizing Agents; D003975:Diazepam
Sperimentazione clinica del Clonazepam (Ro 5-4023 Roche) in età pediatrica.